All Relations between Acromegaly and gh

Publication Sentence Publish Date Extraction Date Species
Seo Young Lee, Jung Hee Kim, Ji Hyun Lee, Yong Hwy Kim, Hyang Jin Cha, Sang Wan Kim, Sun Ha Paek, Chan Soo Shi. The efficacy of medical treatment in patients with acromegaly in clinical practice. Endocrine journal. vol 65. issue 1. 2018-08-17. PMID:28931779. cab was effective in treating acromegaly at a relatively lower cost in patients with low pretreatment gh levels. 2018-08-17 2023-08-13 Not clear
H Alibas, K Uluc, P Kahraman Koytak, M M Uygur, N Tuncer, T Tanridag, D Gogas Yavu. Evaluation of depressive mood and cognitive functions in patients with acromegaly under somatostatin analogue therapy. Journal of endocrinological investigation. vol 40. issue 12. 2018-07-30. PMID:28660605. acromegaly is caused by a pituitary adenoma that releases excess growth hormone (gh) and a concomitant increase in insulin-like growth factor 1 (igf-1). 2018-07-30 2023-08-13 Not clear
Shinjan Patra, Sugata Narayan Biswas, Joydip Datta, Partha Pratim Chakrabort. Hypersomatotropism induced secondary polycythaemia leading to spontaneous pituitary apoplexy resulting in cure of acromegaly and remission of polycythaemia: 'The virtuous circle'. BMJ case reports. vol 2017. 2018-07-16. PMID:29222208. at follow-up after 3 months, resolution of polycythaemia and acromegaly was observed, evident on normal haemoglobin levels, a normocellular marrow, and normal insulin-like growth factor-1 (igf-1) with glucose-suppressed gh levels. 2018-07-16 2023-08-13 Not clear
Christof Schöfl, David Petroff, Anke Tönjes, Martin Grussendorf, Michael Droste, Günter Stalla, Cornelia Jaursch-Hancke, Sylvère Störmann, Jochen Schopoh. Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry. Pituitary. vol 20. issue 6. 2018-06-25. PMID:28808855. acromegaly is a rare disease generally brought about by a benign tumour in the pituitary and characterized by growth hormone (gh) and insulin-like growth factor 1 (igf-1) excess. 2018-06-25 2023-08-13 Not clear
John D Carmichael, Michael S Broder, Dasha Cherepanov, Eunice Chang, Adam Mamelak, Qayyim Said, Maureen P Neary, Vivien Boner. Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center. BMC endocrine disorders. vol 17. issue 1. 2018-05-24. PMID:28778166. acromegaly is a rare, slowly progressive disorder resulting from excessive growth hormone (gh) production by a pituitary somatotroph tumor. 2018-05-24 2023-08-13 Not clear
R Dineen, P M Stewart, M Sherloc. Acromegaly. QJM : monthly journal of the Association of Physicians. vol 110. issue 7. 2018-05-22. PMID:26873451. acromegaly is a rare, chronic, progressive disease characterized by an excess secretion of growth hormone (gh) and increased circulating insulin-like growth factor 1 (igf-1) concentrations. 2018-05-22 2023-08-13 Not clear
R Dineen, P M Stewart, M Sherloc. Acromegaly. QJM : monthly journal of the Association of Physicians. vol 110. issue 7. 2018-05-22. PMID:26873451. therapy for acromegaly is targeted at decreasing gh and igf-1 levels, ameliorating patients' symptoms and decreasing any local compressive effects of the pituitary adenoma. 2018-05-22 2023-08-13 Not clear
R Dineen, P M Stewart, M Sherloc. Acromegaly. QJM : monthly journal of the Association of Physicians. vol 110. issue 7. 2018-05-22. PMID:26873451. the therapeutic options for acromegaly include surgery, medical therapies (such as dopamine agonists, somatostatin receptor agonists and the gh receptor antagonist pegvisomant) and radiotherapy. 2018-05-22 2023-08-13 Not clear
Thalijn Liliana Catharina Wolters, Mihai Gheorghe Netea, Adrianus Rudolfus Marinus Maria Hermus, Johannes Willem Adriaan Smit, Romana Teodora Netea-Maie. IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK. Journal of molecular endocrinology. vol 59. issue 2. 2018-05-10. PMID:28611056. acromegaly is characterized by growth hormone (gh) and insulin-like growth factor 1 (igf1) excess and is accompanied by an increased cardiovascular diseases (cvd) risk. 2018-05-10 2023-08-13 human
Thalijn Liliana Catharina Wolters, Mihai Gheorghe Netea, Adrianus Rudolfus Marinus Maria Hermus, Johannes Willem Adriaan Smit, Romana Teodora Netea-Maie. IGF1 potentiates the pro-inflammatory response in human peripheral blood mononuclear cells via MAPK. Journal of molecular endocrinology. vol 59. issue 2. 2018-05-10. PMID:28611056. whole blood from acromegaly patients and healthy volunteers and peripheral blood mononuclear cells (pbmcs) from healthy volunteers were stimulated with toll-like receptor (tlr) ligands, with or without adding gh or igf1 (in pbmc). 2018-05-10 2023-08-13 human
Patrick Petrossians, Adrian F Daly, Emil Natchev, Luigi Maione, Karin Blijdorp, Mona Sahnoun-Fathallah, Renata Auriemma, Alpha M Diallo, Anna-Lena Hulting, Diego Ferone, Vaclav Hana, Silvia Filipponi, Caroline Sievers, Claudia Nogueira, Carmen Fajardo-Montañana, Davide Carvalho, Vaclav Hana, Günter K Stalla, Marie-Lise Jaffrain-Réa, Brigitte Delemer, Annamaria Colao, Thierry Brue, Sebastian J C M M Neggers, Sabina Zacharieva, Philippe Chanson, Albert Becker. Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database. Endocrine-related cancer. vol 24. issue 10. 2018-05-08. PMID:28733467. acromegaly is a rare disorder caused by chronic growth hormone (gh) hypersecretion. 2018-05-08 2023-08-13 Not clear
G Y Yalin, S Tanrikulu, N Gul, A K Uzum, F Aral, R Tanako. Utility of baseline serum phosphorus levels for predicting remission in acromegaly patients. Journal of endocrinological investigation. vol 40. issue 8. 2018-04-26. PMID:28357781. high gh and igf i levels increase tubular phosphate reabsorption in patients with acromegaly. 2018-04-26 2023-08-13 Not clear
Ian R Wilkinson, Sarbendra L Pradhananga, Rowena Speak, Peter J Artymiuk, Jon R Sayers, Richard J Ros. A long-acting GH receptor antagonist through fusion to GH binding protein. Scientific reports. vol 6. 2018-04-24. PMID:27731358. acromegaly is a human disease of growth hormone (gh) excess with considerable morbidity and increased mortality. 2018-04-24 2023-08-13 human
Christian J Strasburger, Anders Mattsson, Patrick Wilton, Ferah Aydin, Judith Hey-Hadavi, Beverly M K Bille. Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant. European journal of endocrinology. vol 178. issue 4. 2018-04-03. PMID:29371335. increasing frequency of combination medical therapy in the treatment of acromegaly with the gh receptor antagonist pegvisomant. 2018-04-03 2023-08-13 Not clear
Zhanna Belaya, Tatiana Grebennikova, Galina Melnichenko, Alexey Nikitin, Alexander Solodovnikov, Olga Brovkina, Andrey Grigoriev, Liudmila Rozhinskaya, Alexander Lutsenko, Ivan Dedo. Effects of active acromegaly on bone mRNA and microRNA expression patterns. European journal of endocrinology. vol 178. issue 4. 2018-04-03. PMID:29374071. to evaluate the response of bone to chronic long-term growth hormone (gh) and insulin-like growth factor-1 (igf1) excess by measuring the expression of selected mrna and microrna (mir) in bone tissue samples of patients with active acromegaly. 2018-04-03 2023-08-13 Not clear
André Viveiros Monteiro, António Fiarresga, Duarte Cacela, Lídia de Sousa, Ruben Ramos, Ana Galrinho, Luísa Branco, Rui Cruz Ferreir. Alcohol septal ablation in obstructive acromegalic hypertrophic cardiomyopathy - a first case report. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology. vol 35. issue 9. 2018-03-19. PMID:27503591. acromegaly is a rare disease, mostly caused by a growth hormone (gh)-secreting benign pituitary tumor, with an increased production of gh and insulin-like growth factor 1 (igf-1). 2018-03-19 2023-08-13 Not clear
A Ciresi, C Giordan. Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 33. 2018-03-08. PMID:28372721. conversely, in active acromegaly, a condition characterized by a chronic gh excess, both increased and decreased vitamin d levels have been highlighted, and the interplay between vitamin d and the gh/igf-i axis becomes even more complicated when we consider the acromegaly treatment, both medical and surgical. 2018-03-08 2023-08-13 Not clear
G A Mendes, T Haag, G Trott, C G S L Rech, N P Ferreira, M C Oliveira, M B Kohek, J F S Pereira-Lim. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 51. issue 2. 2018-03-08. PMID:29267504. growth hormone (gh)-secreting adenomas account for 13% of all pituitary adenomas and cause acromegaly. 2018-03-08 2023-08-13 Not clear
Pedro Weslley Rosario, Maria Regina Calsolar. Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L. Archives of endocrinology and metabolism. vol 61. issue 5. 2018-02-15. PMID:28977166. to report the results of initial investigation and after 5 years of patients with a suspicious clinical scenario for acromegaly, elevated igf-1, and nadir gh during an oral glucose tolerance test (ogtt) > 0.4 µg/l but < 1 µg/l. 2018-02-15 2023-08-13 Not clear
Russell R Lonser, Gautam U Mehta, Bogdan A Kindzelski, Abhik Ray-Chaudhury, Alexander O Vortmeyer, Robert Dickerman, Edward H Oldfiel. Surgical Management of Carney Complex-Associated Pituitary Pathology. Neurosurgery. vol 80. issue 5. 2018-02-05. PMID:27509071. carney complex (cnc) is a familial neoplasia syndrome that is associated with pituitary-associated hypersecretion of growth hormone (gh) (acromegaly). 2018-02-05 2023-08-13 Not clear